Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 150 of 2909 articles.
Could a bout of COVID protect you from a severe case of flu?
New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity—and potentially better pandemic preparedness.
Researchers may have found an Achilles heel for hepatitis B
New understanding of how the virus replicates could lead to new therapeutic targets for HBV.
How one scientist's fascination with RNA changed medicine forever
Thomas Tuschl has devoted his career to making discoveries that bridge the gap between bench and business—and have resulted in entirely new classes of drugs.
Luciano Marraffini wins Vilcek Prize in Biomedical Science
Marraffini is honored for his pioneering research on the study of CRISPR-Cas systems.
The bacteria that may trigger multiple sclerosis
New research suggests that the long sought-after environmental trigger for MS is a toxin produced by certain C. perfringens bacteria.
Kivanç Birsoy named a 2023 Blavatnik National Awards finalist
Birsoy is honored for groundbreaking research uncovering metabolic weaknesses of diseased cells, such as cancer, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.
Lab-grown mini lungs could accelerate the study of respiratory diseases  
The labs of Ali Brivanlou and Charles M. Rice collaborated to refine a cell culture technology platform that grows genetically identical lung buds from human embryonic stem cells.
New tool to study hepatitis B could open the door to a cure
Just as the Rice lab’s work on HCV exposed that virus’s weaknesses, the hope is that this novel approach could do the same for HBV.
Colorectal cancer tumors both helped and hindered by T cells
Researchers have long disagreed over whether ??T cells in the gut promote or discourage tumor growth, but new evidence suggests they have the capacity to do both.
A third vaccine dose may increase protection from Omicron
The booster appears to galvanize memory B cells into producing potent and versatile antibodies that neutralize both the original virus and its many variants.
Titia de Lange elected to the Royal Society
She receives the honor for elucidating mechanisms of telomere protection and genome maintenance.
Kivanç Birsoy, expert on cancer cell metabolism, is promoted to associate professor 
Birsoy's groundbreaking research has highlighted key nutrients that cancer cells need to survive, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.
New comprehensive map of the portal to the cell’s nucleus
The findings, which may have implications for a wide range of human diseases, suggest that nuclear pore complexes vary in structure and function even within a single nucleus.
New evidence that boosters may be crucial in protecting against Omicron
Researchers found that the antibodies present in people who have had COVID or taken two doses of mRNA vaccine are inadequate against Omicron. But their protective ability increases significantly after a booster dose.
Llama antibodies could help fight SARS-CoV-2 variants
Scientists have identified hundreds of llama-derived antibodies that potentially could be developed into a COVID treatment. They hope such a drug would be potent against different variants of the coronavirus, including Omicron.
Radiotherapy may explain why childhood cancer survivors often develop metabolic disease
Radiation therapy to treat childhood cancer may damage adipose tissue, causing diabetes and coronary heart disease decades later.
Scientists discover how mitochondria import antioxidants
The finding offers researchers a direct way to investigate oxidative stress and its damaging effects in aging, cancer and other diseases.
How foodborne diseases protect the gut's nervous system
Prior infections appear to shield enteric neurons, preventing these key components of the body's "second brain" from dying off when future pathogens strike.
Noninfectious versions of SARS-CoV-2 provide powerful research tools
The new experimental system will facilitate efforts to study different coronavirus variants and develop new drugs for
  • Read more
    • Small molecule may prevent metastasis in colorectal cancer

    The compound works by hindering a key pathway that cancer cells rely upon to hoard energy, and is already undergoing clinical trials.

    Study detects origins of Huntington's disease in two-week-old human embryos
    The findings shed new light on the root causes of this disease, which leads to the degeneration of neurons in midlife.
    Novel method for trapping HIV inside its host may give rise to new antivirals
    Human cells can be coaxed into preventing certain enveloped viruses (including HIV, Ebola, and parainfluenza) from escaping their membranes in the lab, a finding that could lead to novel treatments for many viral diseases.
    Could future coronavirus variants fully dodge our immune system?
    Studying dozens of naturally occurring and laboratory-selected mutations in SARS-CoV-2, researchers found that the virus will need to pull off a genetic feat to become fully resistant to antibodies.
    Toward the first drug to treat a rare, lethal liver cancer
    After scouring more than 5,000 compounds, scientists have identified several new classes of therapeutics that may help treat fibrolamellar carcinoma.
    New findings to boost IVF success rates
    New research casts doubt on a genetic test used to screen would-be embryos for IVF implantation. The findings suggests that these embryos can develop into healthy babies regardless of whether or not they’ve been flagged as defective by the test.
    Paul Cohen, expert on fat, is promoted to associate professor
    Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.
    Immunologist Daniel Mucida promoted to professor
    A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.
    Synthetic “micro lungs” could take COVID-19 research to the next level
    Scientists have developed stem-cell technology to mass-produce tissue cultures resembling our breathing organs. These tissues offer a powerful model in which to study how SARS-CoV-2 wreaks havoc in the lungs and to screen for new drugs.
    As COVID-19 vaccines emerge, the search for antiviral drugs continues
    Scientists are digging through drug libraries of 430,000 compounds, in pursuit of an antiviral drug that can stop the novel coronavirus in its tracks.
    Scientists map the network of SARS-CoV-2’s helpers inside human cells
    The virus must hijack a more than a hundred human proteins to replicate inside a cell. One of them stands out because it is an absolute requirement for infection by four different coronaviruses as well as by viruses that cause Zika, yellow fever, and other diseases.
    Rockefeller issues license for the development of novel anti-inflammatory drug
    The novel compound, discovered in Jan L. Breslow’s lab and now licensed to Bridge Medicines, will be designed to treat immune-mediated diseases without harming the rest of the immune system.
    Rockefeller's Charles M. Rice honored with Nobel Prize for research that contributed to a cure for hepatitis C
    Rice will receive the 2020 Nobel Prize in Physiology or Medicine for research that led to a cure for hepatitis C, a viral disease affecting 170 million people worldwide. His lab worked on the virus for three decades and became the first to produce a version of it that could be grown and studied i...
    Cancer cells use nerve-cell tricks to spread from one organ to the next
    New research suggests that breast and lung tumors metastasize by hijacking a neural signaling pathway, potentially opening the door to better diagnostics and treatments.
    Microbes in the gut may influence metabolism
    A growing number of studies find that microbes in the gut directly influence biological processes from bowel movements to behavior. New research reveals how they impact levels of glucose in the blood.
    Scientists uncover antiviral protein that blocks coronavirus infection
    New research identifies a protein that blocks infection by SARS-CoV-2, the coronavirus that causes COVID-19, along with several other types. The findings could inform treatment strategies and help us better prepare for future outbreaks.
    Study uncovers the molecular events by which popular antidepressants work
    Scientists have outlined a molecular program by which serotonin reuptake inhibitors reshape the brain to alleviate depression. Their findings provide clues for how to make better and faster-acting versions of these drugs.
    Will SARS-CoV-2 escape future drugs by mutating? The answer may be a nuanced “no.”

    Scientists hope to deploy antibodies in the quest to end COVID-19. A recent study moves them closer to accomplishing a key step: finding out if the virus may acquire resistance to antibody-based drugs or vaccines, and how to potent...

    How toothless mock viruses could advance research on COVID-19
    Scientists have engineered four viruses resembling SARS-CoV-2 to enable faster and safer research on vaccines and treatments.
    How neurons in body fat grow to boost calorie-burning capacity
    Scientists have found that a hormone tells the brain to dramatically restructure neurons embedded in fat tissue.  Their work widens our understanding of how the body regulates its energy consumption, and how obesity might be treated in the future.
    Why memory-forming neurons are vulnerable to Alzheimer's
    Scientists have used advanced technology to “micro-dissect” the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets.
    How antibodies from llamas may lead to COVID-19 treatment
    Llamas make antibodies that are much smaller than their human counterparts, yet still potent. Scientists hope that future drugs based on these molecules could provide new weapons against SARS-CoV-2.
    Unique mutation reveals a new role for well-known DNA-repair gene
    The discovery of a rare mutation in BRCA2, commonly known as the breast cancer gene, has shed new light on how cells safeguard their genetic material.
     
    Study reveals first evidence inherited genetics can drive cancer’s spread
    Scientists have long struggled to understand what drives a tumor to seed itself elsewhere in the body. New research implicates our own pre-existing genetics.
    Rockefeller scientists investigate life-threatening inflammation affecting children with COVID-19
    The condition resembles a rare childhood illness, Kawasaki disease. Researchers are analyzing blood samples to find genetic clues to what might be causing it.
    The gene hunt to explain why some young, healthy people die from COVID-19
    People under 50 without preexisting conditions typically develop mild symptoms of coronavirus infection—but there are exceptions. Researchers are working to identify rare genetic variations that may explain why some in this group have succumbed to the disease.
    Rockefeller scientists launch a broad range of studies into novel coronavirus
    Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.
    Small containers inside cells might offer new targets for cancer treatment
    For reasons that have long been unclear, cells stop dividing when the pH rises inside tiny cellular compartments called lysosomes. Now scientists have found an explanation for this phenomenon, with potential implications for drug development.
    Researchers discover a new mechanism in childhood kidney cancer
    A problem in reader proteins that identify which gene is up for expression may cause normal cells to turn malignant during development.
    Scientists develop new method that predicts vulnerability to stress
    Researchers have identified a set of biological factors in mice that seem to determine one's ability to bounce back from a traumatic event, and provide preliminary evidence that a naturally-occurring substance may help boost resiliency in the face of stressful situations.
    Study sheds new light on how epigenetic events might spur disease
    Research that began with the analysis of two developmental syndromes ultimately helped scientists understand how diverse epigenetic mechanisms can combine to drive tissue overgrowth in cancer.
    The pathway to Parkinson’s takes a surprising twist
    A new study finds that neurons affected in Parkinson’s disease can shut down without fully dying, allowing them to also switch off neighboring cells. The findings might give scientists a better understanding of how the condition wreaks havoc in the brain, as well as ideas for new treatments.
    C. David Allis elected to the National Academy of Medicine
    Allis, whose pioneering research established that enzymes that modify histone proteins, which package DNA in the nucleus, regulate gene expression, has been elected to the National Academy of Medicine.
    New research raises prospect of better anti-obesity drugs
    Scientists have found a group of brain cells that influence body mass in two ways, by controlling how much we eat as well as how much energy we burn. The findings could lead to new drugs to help people shed weight.
    New molecular diagnostics test could help guide lupus treatments
    A tool that detects glitches in gene expression could help doctors tailor treatments for lupus-related kidney damage.
    New compounds could be used to treat autoimmune disorders
    In autoimmune disorders, the body’s defense system erroneously attacks normal cells, leading to serious health problems. Researchers have developed new molecules that potentially could be used to treat many of these conditions.
    Researchers find genetic link to tuberculosis
    Rockefeller scientists have identified a genetic condition that makes people prone to developing tuberculosis. In a British population, they found that the condition underlies one percent of cases of the disease—a finding that may ultimately lead to new treatment options.
    New hope for treating a childhood brain cancer
    Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer. But only now have scientists been able to explain how the compound works: by targeting cholesterol production in tumors.
    New approach to treating gastrointestinal disease patches up leaky intestines
    Researchers have discovered a new compound that helps fortify the intestine's inner lining, which becomes porous in inflammatory bowel diseases.  
    Scientists find brain mechanism that naturally combats overeating
    Studying a brain region involved in memory, researchers discovered a set of neurons that help mice control their appetite.
    Researchers discover a common link among diverse cancer types
    Some cancers have been traced to changes in histones, proteins responsible for packaging DNA and regulating genes. Now, research from Rockefeller scientists shows that, among tumors, mutations to these proteins are a lot more common than previously suspected.
    View
    View